NEW YORK, NY--(Marketwire - March 17, 2008) - Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced the publication in the Hawaii Medical Journal of “Circulating Blood Volume Measurements Correlate Poorly with Pulmonary Artery Catheter Measurements,” which demonstrated clinical benefit of the Blood Volume Analyzer BVA-100 to critically ill surgical patients.
